Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) is one of the best biotech stocks to buy according to Wall Street analysts.
Massachusetts Institute of Technology professor Phillip Sharp co-founded Alnylam with several others in 2002. It wasn't Sharp ...
Idorsia’s dual orexin receptor antagonist, the first and only drug of its kind approved in Europe for the treatment of ...
Amid a challenging climate for Vancouver’s life sciences sector, Zymeworks Inc. (Nasdaq:ZYME) stands out as a success story ...
In the northwest corner of Sioux Falls, an 80-acre campus opened its first building this year dedicated entirely to expanding ...
Biomarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the best biotech stocks to buy according to Wall Street analysts.
With regulators across Asia-Pacific easing pathways for new therapies, Dimerix is positioning DMX-200 for one of the world’s ...
French biotech company Abivax's shares rose by over 20% on Wednesday on market rumours that U.S. pharma giant Eli Lilly could ...
GlobalData on MSN
Crescent and Kelun-Biotech swap cancer asset rights in double deal
The strategic partnership sees two separate financial deals for the pair of oncology assets. Rights to Kelun’s integrin ...
This research led to Balu-Iyer founding the Buffalo-based company Immune Modulatory Therapies LLC in 2019. His UB co-founders ...
Seventy-three pharmaceutical, biotechnology and medical device companies from mainland China filed for IPOs in Hong Kong this year, a review by BioWorld found. In the second half of 2025, 43 new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback